Dr Jeremy Morrison, DO - Medicare Family Practice in Brattleboro, VT

Dr Jeremy Morrison, DO is a medicare enrolled "Family Medicine" physician in Brattleboro, Vermont. He went to Lake Erie College Of Osteopathic Medicine, Erie and graduated in 2013 and has 11 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Carlos G Otis Health Care Center Inc and his current practice location is 62 Elliot St, Brattleboro, Vermont. You can reach out to his office (for appointments etc.) via phone at (802) 490-1904.

Dr Jeremy Morrison is licensed to practice in Massachusetts (license number 256686) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1154769685.

Contact Information

Dr Jeremy Morrison, DO
62 Elliot St,
Brattleboro, VT 05301-3208
(802) 490-1904
(802) 738-0087



Physician's Profile

Full NameDr Jeremy Morrison
GenderMale
SpecialityFamily Practice
Experience11 Years
Location62 Elliot St, Brattleboro, Vermont
Accepts Medicare AssignmentsMay be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Jeremy Morrison attended and graduated from Lake Erie College Of Osteopathic Medicine, Erie in 2013
  NPI Data:
  • NPI Number: 1154769685
  • Provider Enumeration Date: 06/06/2013
  • Last Update Date: 04/07/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 5193023950
  • Enrollment ID: I20160920000966

Medical Identifiers

Medical identifiers for Dr Jeremy Morrison such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154769685NPI-NPPES
1027050MedicaidVT

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 256686 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Grace Cottage HospitalTownshend, VTHospital
Brattleboro Memorial HospitalBrattleboro, VTHospital
Cheshire Medical CenterKeene, NHHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Carlos G Otis Health Care Center Inc600272638726

News Archive

FDA ODAC votes in favor of Onyx's Kyprolis

Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.

New study explores impact of infant feeding practices on childhood obesity risk

Does the timing of introducing solid foods to the infant diet affect a child's risk of being obese by 6 years of age? A new study from the Centers for Disease Control and Prevention (CDC) analyzed data on infant feeding practices, with a 6-year follow-up to determine obesity, and also explored the potential impact of breast versus formula feeding.

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.

Significant SARS-CoV-2 vaccine hesitancy in the U.S.

A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).

Study examines the phenomenon of visual illusions in convolutional networks

A convolutional neural network is a type of artificial neural network in which the neurons are organized into receptive fields in a very similar way to neurons in the visual cortex of a biological brain.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Jeremy Morrison allows following entities to bill medicare on his behalf.
Entity NameCarlos G Otis Health Care Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124049960
PECOS PAC ID: 6002726387
Enrollment ID: O20040802001147

News Archive

FDA ODAC votes in favor of Onyx's Kyprolis

Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.

New study explores impact of infant feeding practices on childhood obesity risk

Does the timing of introducing solid foods to the infant diet affect a child's risk of being obese by 6 years of age? A new study from the Centers for Disease Control and Prevention (CDC) analyzed data on infant feeding practices, with a 6-year follow-up to determine obesity, and also explored the potential impact of breast versus formula feeding.

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.

Significant SARS-CoV-2 vaccine hesitancy in the U.S.

A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).

Study examines the phenomenon of visual illusions in convolutional networks

A convolutional neural network is a type of artificial neural network in which the neurons are organized into receptive fields in a very similar way to neurons in the visual cortex of a biological brain.

Read more Medical News

› Verified 3 days ago

Entity NameBrattleboro Memorial Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306849708
PECOS PAC ID: 9335112929
Enrollment ID: O20040929000782

News Archive

FDA ODAC votes in favor of Onyx's Kyprolis

Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.

New study explores impact of infant feeding practices on childhood obesity risk

Does the timing of introducing solid foods to the infant diet affect a child's risk of being obese by 6 years of age? A new study from the Centers for Disease Control and Prevention (CDC) analyzed data on infant feeding practices, with a 6-year follow-up to determine obesity, and also explored the potential impact of breast versus formula feeding.

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.

Significant SARS-CoV-2 vaccine hesitancy in the U.S.

A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).

Study examines the phenomenon of visual illusions in convolutional networks

A convolutional neural network is a type of artificial neural network in which the neurons are organized into receptive fields in a very similar way to neurons in the visual cortex of a biological brain.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jeremy Morrison is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Jeremy Morrison, DO
62 Elliot St,
Brattleboro, VT 05301-3208

Ph: (802) 490-1904
Dr Jeremy Morrison, DO
62 Elliot St,
Brattleboro, VT 05301-3208

Ph: (802) 490-1904

News Archive

FDA ODAC votes in favor of Onyx's Kyprolis

Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.

New study explores impact of infant feeding practices on childhood obesity risk

Does the timing of introducing solid foods to the infant diet affect a child's risk of being obese by 6 years of age? A new study from the Centers for Disease Control and Prevention (CDC) analyzed data on infant feeding practices, with a 6-year follow-up to determine obesity, and also explored the potential impact of breast versus formula feeding.

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.

Significant SARS-CoV-2 vaccine hesitancy in the U.S.

A new study has found that an alarming amount of parents in the United States say they are unlikely to vaccinate their children or themselves against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome (SARS-CoV-2).

Study examines the phenomenon of visual illusions in convolutional networks

A convolutional neural network is a type of artificial neural network in which the neurons are organized into receptive fields in a very similar way to neurons in the visual cortex of a biological brain.

Read more News

› Verified 3 days ago


Family Medicine Doctors in Brattleboro, VT

Craig E Goldberg, DO
Family Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 1027 Western Avenue, Brattleboro, VT 05301
Phone: 802-254-4545    Fax: 802-254-0079
Robert Edmund Tortolani, M.D.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 63 Belmont Ave, Suite 1, Brattleboro, VT 05301
Phone: 802-254-1113    
Kathleen Burgess, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 19 Belmont Ave Ste 103, Brattleboro, VT 05301
Phone: 802-258-3905    
Dr. Tony Blofson, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 120 Maple St, Brattleboro, VT 05301
Phone: 802-254-1311    
Dr. Denise Paasche, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 120 Maple St, Brattleboro, VT 05301
Phone: 802-254-1311    
Janine Lynn Foote, DO
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 21 Belmont Ave, Suite2, Brattleboro, VT 05301
Phone: 802-257-7792    Fax: 802-254-7001

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.